FOS and Alzheimer disease: Dysregulation in IEGs has been implicated in many neurological diseases, including increased circulating Egr1 in schizophrenia [77, 78], increased Arc in the amygdala in major depressive disorder [79, 80], and increased cFos and cJun in the hippocampus and amygdala in AD [81–83].